Selera Medical: One-time, device-based treatment for heart failure Features
Selera Medical is developing a one-time, minimally invasive device-based treatment for fluid overload in heart failure patients.
View MoreKey Features of Selera Medical: One-time, device-based treatment for heart failure
Selera Medical is developing a one-time, minimally invasive device-based treatment for heart failure called MILO (minimally invasive lymphatic offloading). It aims to manage fluid overload in heart failure patients by leveraging the body's innate fluid management system to offload trapped fluid and prevent subsequent buildup. This approach is designed to provide long-term treatment and break the cycle of fluid overload hospitalizations, offering an alternative to current medications that can have side effects and become ineffective over time.
One-time procedure: MILO is designed to be a single, minimally invasive procedure that provides long-term treatment.
Leverages natural systems: The device works with the body's innate fluid management system to address fluid overload.
Breaks hospitalization cycle: Aims to reduce frequent hospitalizations associated with fluid overload in heart failure patients.
Alternative to medications: Offers a device-based approach that may avoid side effects and decreasing efficacy of traditional medications.
Use Cases of Selera Medical: One-time, device-based treatment for heart failure
Advanced heart failure treatment: For patients with severe heart failure who have limited options with current treatments.
Reducing hospital readmissions: Hospitals could use this to help reduce readmission rates for heart failure patients.
Improving quality of life: Patients may experience improved daily functioning and reduced symptoms.
Research and clinical trials: Cardiologists and interventional radiologists can partner for product testing and future clinical trials.
Pros
Potential for long-term treatment from a single procedure
May reduce need for ongoing medication management
Could significantly improve patient quality of life
Cons
New technology that requires further testing and validation
May not be suitable for all heart failure patients
Potential risks associated with a device-based approach
Popular Articles
Claude 3.5 Haiku: Anthropic's Fastest AI Model Now Available
Dec 13, 2024
Uhmegle vs Chatroulette: The Battle of Random Chat Platforms
Dec 13, 2024
12 Days of OpenAI Content Update 2024
Dec 13, 2024
Best AI Tools for Work in 2024: Elevating Presentations, Recruitment, Resumes, Meetings, Coding, App Development, and Web Build
Dec 13, 2024
View More